CLAIM #6327 · Amgen Inc (AMGN) · 2026Q1 earnings call · Apr 30, 2026 · due Dec 31, 2026
“We now anticipate non-GAAP OI&E to be in the range of $2.2 billion to $2.3 billion of expense in 2026.”
Peter Griffith · CFO
How to check this claim
Look at: Non-GAAP other income and expense (OI&E), full fiscal year 2026
It came true if: Non-GAAP OI&E expense between $2.2 billion and $2.3 billion
Where: Company non-GAAP reconciliation tables in Q4 2026 earnings release / 10-K
In context
“t quarter, we expect 2026 to be a springboard year for future growth. Our strong first quarter performance reinforces that outlook, and we are raising our 2026 guidance ranges for both revenue and non-GAAP earnings per share. We expect 2026 total revenues in the range of $37.1 billion to $38.5 billion and non-GAAP earnings per share to be between $21.70 and $23.10. These ranges reflect our confidence that the emerging growth drivers will more than offset the outgoing legacy brands. Note, our guidance does not include any potential business development transactions that may occur throughout the remainder of the year. Let me highlight a few updates to our outlook for the remainder of the year. For the full year, we now expect other revenue to be in the range of $1.7 billion to $1.8 billion. We now anticipate non-GAAP OI&E to be in the range of $2.2 billion to $2.3 billion of expense in 2026. We now expect a non-GAAP tax rate in the range of 15% to 16.5%. And let me remind you of prior items that have not changed. We continue to expect the full-year non-GAAP operating margin as a percentage of product sales to be roughly 45% to 46%. This reflects our commitment to investing in the best innovation as we continue to rapidly advance the Meritide Phase III program and additional key late-stage assets. We expect share repurchases not to exceed $3 billion. Finally, in regard to our ongoing tax litigation, the tax court litigation covering tax years 2010 through 2015 remains ongoing, and while we expect a decision no earlier than the 2020, we remain confident in the case we presented at trial. We are currently under audit by the IRS for the 2016 to 2018 tax years. In April 2026, we r”
Verify independently
SEC filings for AMGN ↗ · Claim quote is verbatim from the 2026Q1 earnings call.